PAP — Drug Target

All drugs that target PAP — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Autologous Cellular Immunotherapy [EPC]

Marketed (1)

• SIPULEUCEL-T · Autologous Cellular Immunotherapy [EPC]
  PROVENGE induces an immune response against PAP, an antigen found in most prostate cancers.